Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes

Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes

US Patent 9555089 · Granted Jan 31, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and gly2017
Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and gly2016
Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as2015
C—glycolipids with enhanced Th-1 profile2014
Glycolipids and analogues thereof as antigens for NKT cells2013
Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and2012
Glycolipids and analogues thereof as antigens for NKT cells2012
Glycolipids and analogues thereof as antigens for NKT cells2011
Identification marker responsive to interferon therapy for renal cell cancer2010
Use of synthetic glycolipids as universal adjuvants for vaccines against cancer 2010
Glycolipids and analogues thereof as antigens for NK T cells2009
Use of glycosylceramides as adjuvants for vaccines against infections and cancer2009